Evidence map›Paper›PMID 26528486›Full record

ArticleMolecular neuropsychiatry2015

Association Study of Genotype by Depressive Response during Tryptophan Depletion in Subjects Recovered from Major Depression.

Francisco A Moreno, Robert P Erickson, Holly A Garriock, Joel Gelernter, Jim Mintz, Jennifer Oas-Terpstra, Marilyn A Davies, Pedro L Delgado

Open access · bronzeAbstract read
In one paragraph

Article in Molecular neuropsychiatry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. mGluR5 Facilitates Long-Term Synaptic Depression in a Stress-Induced Depressive Mouse Model.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2020
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 2 countries.

Francisco A MorenoDepartment of Psychiatry, College of Medicine, The University of Arizona Health Sciences Center, USA.
Robert P EricksonDepartment of Pediatrics, College of Medicine, The University of Arizona Health Sciences Center, USA.
Holly A GarriockDivision of Translational Research (DTR), National Institute of Mental Health, USA.
Joel GelernterDepartment of Psychiatry, Yale University School of Medicine, VA Connecticut Health Care Center, USA.
Jim MintzDepartment of Psychiatry, University of Texas Health Sciences Center San Antonio, USA.
Jennifer Oas-TerpstraDepartment of Physiology, College of Medicine, The University of Arizona Health Sciences Center, USA.
Marilyn A DaviesHealth and Community Systems, University of Pittsburgh School of Nursing, USA.
Pedro L DelgadoDepartment of Psychiatry, University of Arkansas for Medical Sciences, USA.
University of Arizona · USNational Institute of Mental Health · CZPediatrics and Genetics · USThe University of Texas Health Science Center at San Antonio · USUniversity of Arkansas for Medical Sciences · USUniversity of Pittsburgh · USYale University · US

Funding

Tryptophan Depletion: A Phenotypic Marker for DepressionR01MH066235 · NIMH · UNIVERSITY OF ARIZONA · PI MORENO, FRANCISCO A · 2003 to 2007
$2.3M
NIMH NIH HHS R01 MH066235
6 · The paper itself

Abstract

purposeThe brief and reversible mood response to acute tryptophan (TRP) depletion (ATD) is being studied as a trait marker in subjects considered at risk for major depression (MD). PROCEDURES: ATD was administered to 64 subjects (54 European-Americans, and10 from other races) with personal and family history of MD. They were in remission and had been medication-free for at least three months. Subjects received an active and sham condition in a random assignment, double-blind crossover design. They were genotyped for serotonin-related candidate genes, and mood response was quantified with the Hamilton Depression Rating Scale (HDRS). Data were analyzed using Poisson regression with repeated measures and latent trajectory models.

resultsCompared to the sham control, active ATD caused modest depressive changes showing significant main effects of test condition (χ CONCLUSIONS AND MESSAGE: ATD may help the identification of biological subtypes of MD. These data are consistent with imaging reports implicating 5-HT2A receptor function in ATD phenotypes.

Indexed as

Depression EndophenotypeNeurotransmitter DepletionSerotonin Candidate Genes (SLC6A4, 5-HTTLPR, STin2, HTR1A, HTR2A, TPH2)

Identifiers

PMID26528486
PMCPMC4627710
OpenAlexW2180405123

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.